Charged Liposome Fusion for Lysis-Free EV Gene Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting tumor cell-derived extracellular vesicle RNA are laborious, time-consuming, and face challenges in distinguishing tumor cell-derived RNA signals due to the complexity of biological samples and the need for complex genetic manipulations, limiting their utility in clinical scenarios.
Innovation Solution
A charged-liposome system comprising cationic and neutral lipids is developed for efficient fusion with extracellular vesicles, enabling high-throughput miRNA or mRNA profiling by sorting individual EVs in emulsion droplets, utilizing a charge-induced fusion method that simplifies the detection process and enhances sensitivity and selectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods (EV isolation, lysis, RNA extraction, reverse transcription amplification) are used for detecting EV-derived RNA, then detection capability is provided, but the process becomes laborious and time-consuming
Solution Approach 1:
The invention extracts and utilizes the membrane fusion capability of EVs as a direct detection mechanism, eliminating the need for separate isolation, lysis, and extraction steps. By using fluorescently labeled liposomes that fuse with EV membranes, the method directly detects EV presence and characteristics in a single step, dramatically reducing process time while maintaining detection precision.
Solution Approach 2:
The invention replaces the complex mechanical and chemical process of EV isolation and RNA extraction with a simpler membrane fusion-based detection system. The fluorescent liposome fusion method substitutes for multiple manual steps including centrifugation, filtration, and molecular biology techniques, reducing both time and labor requirements.
2Ease of operation
If bulk solution methods are used for RNA isolation and analysis, then processing is simplified, but the ability to distinguish tumor cell-derived RNA signals is compromised
Solution Approach 1:
The invention segments the detection process at the single EV level rather than analyzing bulk solution RNA. By detecting individual EVs through membrane fusion with fluorescent liposomes, the method preserves the ability to distinguish tumor-derived signals from normal cells while maintaining operational simplicity. Each EV is processed and detected independently, preventing signal averaging that occurs in bulk methods.
Solution Approach 2:
The invention applies local quality detection by targeting specific EV subpopulations through membrane fusion characteristics. The fluorescent liposome method allows differentiation based on local EV properties such as membrane composition, size, and fusion kinetics, enabling distinction between tumor and normal cell-derived EVs without requiring complex bulk RNA analysis.
3Measurement precision
If complex genetic manipulations are used for EV detection, then detection specificity is improved, but the method becomes technically challenging and time-consuming
Solution Approach 1:
The invention employs self-service detection where the EV membrane itself serves as the detection target. The fluorescent liposome automatically fuses with EV membranes through charge-mediated interactions, eliminating the need for complex genetic manipulations or protein engineering. The EV's own membrane properties enable the detection process, simplifying the methodology while maintaining high specificity.
Solution Approach 2:
The invention utilizes parameter changes in liposome composition (charge, size, membrane fluidity) to achieve specific detection outcomes. By adjusting liposome surface charge and membrane properties, the method achieves high specificity for tumor-derived EVs through physical chemistry parameters rather than complex genetic manipulations, reducing technical difficulty while maintaining detection precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for high-sensitivity and high-selectivity detection of cancer cell-derived extracellular vesicle genes, minimizing EV loss and facilitating rapid, accurate diagnosis of cancer through fluorescence signaling.
Implementation Method 1
a charged-liposome system comprising cationic and neutral lipids is developed for efficient fusion with extracellular vesicles, utilizing a charge-induced fusion method
Implementation Method 2
facilitating rapid, accurate diagnosis of cancer through fluorescence signaling
Data Source
AI summary
The present invention successfully introduced a new approach to target specific EV subpopulations on the basis of charge-mediated fusion of EVs and CLIPs. By adjusting the surface charge of liposomes through the ratio of positively and negatively charged lipids, the optimal ratio that allows efficient and stable fusion with exosomes was confirmed. A method according to the present invention uses the advantages of a CLIP's high fusion rate, and rapid and broad applicability, and verified excellent sensitivity and selectivity for disease-derived EV miRNA in a lysis-free manner using droplet-microfluidics. Particularly, the EV-CLIP method enables digital detection of EGFR L858R and T790M mutations without pretreating a sample, and thus can simplify detection processes and prevent EV loss.